Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis
Authors
Keywords
-
Journal
HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-03-15
DOI
10.1002/hep.29881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis
- (2017) Dai-Min Xiang et al. GUT
- The origin of fibrogenic myofibroblasts in fibrotic liver
- (2017) Tatiana Kisseleva HEPATOLOGY
- Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
- (2017) Yuko Tokunaga et al. Scientific Reports
- Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL
- (2016) P. M. Barr et al. BLOOD
- Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease
- (2016) Terence N. Bukong et al. HEPATOLOGY
- Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway
- (2016) Kuan-Hsing Chen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney
- (2016) Frank Y. Ma et al. LIFE SCIENCES
- Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells
- (2016) Besma Aouar et al. PLoS One
- S100A4 promotes liver fibrosis via activation of hepatic stellate cells
- (2015) Lin Chen et al. JOURNAL OF HEPATOLOGY
- High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers
- (2015) Ingmar Mederacke et al. Nature Protocols
- Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
- (2014) Ali A Mokdad et al. BMC Medicine
- Expression of Variant Isoforms of the Tyrosine Kinase SYK Determines the Prognosis of Hepatocellular Carcinoma
- (2014) Jian Hong et al. CANCER RESEARCH
- Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase
- (2014) Kevin S. Currie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-Risk Precursor B Cell Acute Lymphoblastic Leukemia
- (2014) T. Perova et al. Science Translational Medicine
- Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
- (2013) Bryan C. Fuchs et al. HEPATOLOGY
- PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis
- (2012) Weiwei Yang et al. CELL
- Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
- (2012) Juliane S. Troeger et al. GASTROENTEROLOGY
- CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma
- (2012) Jian Hong et al. JOURNAL OF CLINICAL INVESTIGATION
- An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis
- (2010) Michael E. Weinblatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptional regulation of hepatic stellate cells
- (2009) Jelena Mann et al. ADVANCED DRUG DELIVERY REVIEWS
- Proteomic and Genetic Approaches Identify Syk as an AML Target
- (2009) Cynthia K. Hahn et al. CANCER CELL
- Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis
- (2009) Gakuhei Son et al. HEPATOLOGY
- Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress
- (2008) Henry E. Speich et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Senescence of Activated Stellate Cells Limits Liver Fibrosis
- (2008) Valery Krizhanovsky et al. CELL
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started